Surekha Yadav, MBBS

Title(s)Resident, Radiology
SchoolSchool of Medicine
Address505 Parnassus Avenue, #L352
San Francisco CA 94117
Phone415-342-8354
PronounsShe/Her/Hers
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data. J Nucl Med. 2025 May 22. Akhavanallaf A, Lu Z, Peterson AB, Blakkisrud J, Kurkowska S, Yadav S, Wang C, Uribe C, Stokke C, Rahmim A, Wong KK, Beauregard JM, Hope TA, Sjögreen Gleisner K, Dewaraja YK. PMID: 40404396.
      View in: PubMed   Mentions:    Fields:    
    2. Pre- or post-chemotherapy: effect on PSMA uptake. EJNMMI Res. 2025 Apr 07; 15(1):36. Yadav S, Tuchayi AM, Moradpour M, Jiang F, Juarez R, de Kouchkovsky I, Flavell RR, Aggarwal RR, Hope TA. PMID: 40192880; PMCID: PMC11977060.
      View in: PubMed   Mentions:
    3. Impact of Posttreatment SPECT/CT on Patient Management During 177Lu-PSMA-617 Radiopharmaceutical Therapy. J Nucl Med. 2024 Sep 03; 65(9):1395-1401. Yadav S, Lowery B, Tuchayi AM, Jiang F, Saelee R, Aggarwal RR, Juarez R, Flavell RR, Hope TA. PMID: 39117452.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After Injection. J Nucl Med. 2024 Jul 01; 65(7):1064-1069. Yadav S, Jiang F, Kurkowska S, Saelee R, Morley A, Feng F, Aggarwal R, Lawhn-Heath C, Uribe C, Hope TA. PMID: 38724282.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Comparison of 18F-DCFPyL and 68Ga-PSMA-11 for 177Lu-PSMA-617 therapy patient selection. Front Oncol. 2024; 14:1382582. Yadav S, Kim ST, Tuchayi AM, Jiang F, Morley A, Saelee R, Wang Y, Juarez R, Lawnh-Heath C, Koshkin VS, Hope TA. PMID: 38993644; PMCID: PMC11238039.
      View in: PubMed   Mentions:
    6. 68Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with 18F-FDG. J Nucl Med. 2024 Jun 03; 65(6):938-943. Kline B, Yadav S, Seo Y, Ippisch RC, Castillo J, Aggarwal RR, Kelley RK, Behr SC, Flavell RR, Lawhn-Heath C, Melisko M, Rugo HS, Wang V, Yom SS, Ha P, Jiang F, Hope TA. PMID: 38697672; PMCID: PMC11149593.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    7. Actinium-225 targeted alpha particle therapy for prostate cancer. Theranostics. 2024; 14(7):2969-2992. Bidkar AP, Zerefa L, Yadav S, VanBrocklin HF, Flavell RR. PMID: 38773983; PMCID: PMC11103494.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    8. Real-World Experience with 177Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval. J Nucl Med. 2024 May 01; 65(5):735-739. Moradi Tuchayi A, Yadav S, Jiang F, Kim ST, Saelee RK, Morley A, Juarez R, Lawhn-Heath C, Wang Y, de Kouchkovsky I, Hope TA. PMID: 38485274; PMCID: PMC11927062.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy. J Nucl Med. 2024 Mar 01; 65(3):409-415. Yadav S, Lawhn-Heath C, Paciorek A, Lindsay S, Mirro R, Bergsland EK, Hope TA. PMID: 38428966; PMCID: PMC11927066.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Cytological evaluation of pericardial fluids: A 5 years experience in tertiary care center. Indian J Pathol Microbiol. 2019 Apr-Jun; 62(2):270-273. Yadav S, Singh M, Singh P, Mandal S, Khurana N, Jain SL. PMID: 30971553.
      View in: PubMed   Mentions:
    Surekha's Networks
    Concepts (50)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.